Patients with salivary gland cancer (SGC) were less likely than those without SGC to show positive PD‐L1 expression (CPS, 55.6% vs. 81.8%, p = 0.08; TPS, 44.4% vs. 77.3%, p = 0.04). This evidence concerns the gene CD274 and salivary gland cancer.